DXCM Q2 2023 Earnings — DexCom, Inc. Revenue & Financial Results | Market Cap Arena

DXCMDexCom, Inc.

$27B

Q2 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$871M+25.2% YoY

Gross Profit

$546M62.7% margin

Operating Income

$128M14.7% margin

Net Income

$116M13.3% margin

EPS (Diluted)

$0.28

QoQ Revenue Growth

+17.5%

Cash Flow

Operating Cash Flow

$190M

Free Cash Flow

$131M

Stock-Based Comp.

$40M

Balance Sheet

Total Assets

$6.8B

Total Liabilities

$4.7B

Stockholders' Equity

$2.1B

Cash & Equivalents

$1.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$871M	$696M	+25.2%
Gross Profit	$546M	$450M	+21.6%
Operating Income	$128M	$77M	+66.4%
Net Income	$116M	$51M	+127.7%

Geographic Segments

UNITED STATES

$617M71%

Non-US

$255M29%